Tetra Receives its 4th FDA Orphan Drug Designation
OTTAWA / ACCESSWIRE / April 16, 2020 / Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP);(OTCQB:TBPMF), a leader in cannabinoid-derived drug
Read more
FDA
OTTAWA / ACCESSWIRE / April 16, 2020 / Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP);(OTCQB:TBPMF), a leader in cannabinoid-derived drug
Read more